Armistice Capital buys $18,673,200 stake in Healthways (HWAY)

Healthways (HWAY) : Armistice Capital scooped up 120,000 additional shares in Healthways during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 840,000 shares of Healthways which is valued at $18,673,200.Healthways makes up approximately 8.40% of Armistice Capital’s portfolio.

Other Hedge Funds, Including , Hbk Investments L P reduced its stake in HWAY by selling 12,839 shares or 27.19% in the most recent quarter. The Hedge Fund company now holds 34,374 shares of HWAY which is valued at $764,134. Healthways makes up approx 0.02% of Hbk Investments L P’s portfolio. Tfs Capital sold out all of its stake in HWAY during the most recent quarter. The investment firm sold 77,045 shares of HWAY which is valued $1,712,710.Tower Research Capital (trc) boosted its stake in HWAY in the latest quarter, The investment management firm added 1,686 additional shares and now holds a total of 1,977 shares of Healthways which is valued at $43,949.

Healthways closed down -0.15 points or -0.60% at $24.86 with 6,30,130 shares getting traded on Thursday. Post opening the session at $25.2, the shares hit an intraday low of $24.4 and an intraday high of $25.51 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Healthways reported $0.54 EPS for the quarter, beating the analyst consensus estimate by $ 0.53 according to the earnings call on Aug 9, 2016. Analyst had a consensus of $0.01. The company had revenue of $125.00 million for the quarter, compared to analysts expectations of $190.21 million. The company’s revenue was up 10.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.11 EPS.

Many Wall Street Analysts have commented on Healthways. Company shares were Upgraded by Barclays on Aug 22, 2016 to ” Equal Weight”, Firm has raised the Price Target to $ 27 from a previous price target of $12 .Company shares were Reiterated by FBR Capital on Aug 12, 2016 to “Outperform”, Firm has raised the Price Target to $ 28 from a previous price target of $21 .Company shares were Reiterated by Piper Jaffray on Aug 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 25.50 from a previous price target of $15 .

Healthways Inc. (Healthways) provides total population health management solutions designed to help people improve well-being thereby improving health and productivity and reducing health-related costs. The Company’s well-being improvement programs provide personalized solutions for any individual irrespective of the health status age or paying sponsor. Its population health platform using analytics and predictive models enables to stratify the population develop individualized well-being improvement plans and deliver action-based solutions to improve individual and organizational performance. Through this data-driven process the Company identifies the needs of each individual in a population and determines the right level of support. The Company’s services are delivered using venue-based face-to-face interactions; print; phone; mobile and remote devices; online including social networks and any combination of these methods to motivate and sustain healthy behaviors.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Healthways - Is it time to Sell?

Top Brokerage Firms are advising their investors on Healthways. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.